Microbix Biosystms (TSE:MBX) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Microbix Biosystems has announced successful validation of its HPV Quality Assessment Product (QAP) for self-collected samples, showing 100% concordance across various media and assays. This advancement could enhance cervical cancer screening by allowing more women to participate through home sample collection.
For further insights into TSE:MBX stock, check out TipRanks’ Stock Analysis page.
